Effects of intranasal budesonide on symptoms, quality of life, and performance in elite athletes with allergic rhinoconjunctivitis

Clinical Journal of Sport Medicine

Volumn 12, Issue 5, 2002, Pages 296-300

  Katelaris, Constance H ^a   Carrozzi, Fiona M ^a   Burke, Therese V ^a   Byth, Karen ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Allergic rhinoconjunctivitis; Athletes; Budesonide; Treatment

Indexed keywords

BUDESONIDE;

ADULT; ARTICLE; ATHLETE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHINOCONJUNCTIVITIS; SYMPTOMATOLOGY;

ADMINISTRATION, INTRANASAL; ADULT; AIR POLLUTION; ANALYSIS OF VARIANCE; AUSTRALIA; BUDESONIDE; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; MALE; POLLEN; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; SEASONS; SEVERITY OF ILLNESS INDEX; SPORTS; TREATMENT OUTCOME;

EID: 0036748543     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042752-200209000-00007     Document Type: Article

References (13)

1. Steensen H, Lindqvist N. Treatment of grass pollen-induced hay fever with intranasal budesonide. Allergy 1981;36:245-249.
2. Bousquet J, Bullinger M, Fayol C, et al. Assessment of Quality of Life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182-188.
3. Katelaris CH, Carrozzi FM, Burke TV, et al. A springtime Olympics demands special consideration for allergic athletes. J Allergy Clin Immunol 2000;106:260-266.
4. Burke TV, Katelaris CH. Pollen profile of the Year 2000 Olympic games venues in Sydney Australia [Abstract]. J Allergy Clin Immunol 2000;105:S236.
5. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinitis. Clin Exp Allergy 1991;21:77-83.
6. Juniper EF, Guyatt G, Dolovich J. Assessment of Quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413-423.
7. Juniper EF, Guyatt G, Anderson B, et al. Comparison of the efficacy and side effects of intranasal budesonide administered as powder and pressurised aerosol in perennial rhinitis: validation of the rhinitis quality of life questionnaire. Ann Allergy 1993;70:225-30.
8. Juniper EF, Guyatt G, O'Byrne PM, et al. Aqueous beclomethasone dipropionate nasal spray regular versus 'as required' use in treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1990;86:380-86.
9. Helenius IJ. Tikkanen HO, Sarna S, et al. Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors. J Allergy Clin Immunol 1998;101:646-652.
10. Helbling A, Jenoure P, Muller U. The incidence of hayfever in leading Swiss athletes. Schweiz Med Wochenschr 1990;17:120:231-236.
11. Fitch KD. Management of allergic Olympic athletes. J Allergy Clin Immunol 1984;73:722-727.
12. 1 receptor antagonists in allergic rhinitis: systematic review of randomised trials. BMJ 1998;317:424-29.
13. Commonwealth Sports Drug Agency. Drugs in Sport Handbook. 3rd ed. Canberra: National Capital Printing, 1997.